Monte Rosa Therapeutics, Inc.
GLUE
$15.50
-$0.34-2.15%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 621.10M | 666.22M | 377.10M | 391.26M | 290.59M |
| Total Receivables | 4.92M | 4.61M | 11.60M | 4.97M | 2.37M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.38M | 6.72M | 4.48M | 5.59M | 6.50M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 631.41M | 677.55M | 393.19M | 401.82M | 299.47M |
|
|
|||||
| Total Current Assets | 631.41M | 677.55M | 393.19M | 401.82M | 299.47M |
| Net Property, Plant & Equipment | 53.99M | 53.10M | 50.37M | 52.66M | 54.73M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.77M | 5.78M | 5.10M | 5.36M | 5.40M |
| Total Assets | 691.16M | 736.43M | 448.66M | 459.84M | 359.59M |
|
|
|||||
| Total Accounts Payable | 7.15M | 7.90M | 3.55M | 14.51M | 5.58M |
| Total Accrued Expenses | 23.96M | 21.69M | 25.12M | 16.25M | 12.26M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.63M | 4.48M | 4.40M | 4.24M | 4.09M |
| Total Finance Division Other Current Liabilities | 23.92M | 36.97M | 31.15M | 26.44M | 19.92M |
| Total Other Current Liabilities | 23.92M | 36.97M | 31.15M | 26.44M | 19.92M |
| Total Current Liabilities | 59.66M | 71.04M | 64.21M | 61.44M | 41.85M |
|
|
|||||
| Total Current Liabilities | 59.66M | 71.04M | 64.21M | 61.44M | 41.85M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 33.36M | 34.58M | 34.79M | 35.93M | 37.04M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 110.87M | 108.90M | 116.60M | 116.63M | 12.62M |
| Total Liabilities | 203.88M | 214.51M | 215.60M | 214.00M | 91.51M |
|
|
|||||
| Common Stock & APIC | 1.06B | 1.05B | 714.10M | 680.16M | 675.45M |
| Retained Earnings | -565.11M | -521.72M | -477.21M | -431.08M | -404.00M |
| Treasury Stock & Other | -5.17M | -4.75M | -3.83M | -3.25M | -3.37M |
| Total Common Equity | 487.28M | 521.92M | 233.06M | 245.84M | 268.08M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 487.28M | 521.92M | 233.06M | 245.84M | 268.08M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 487.28M | 521.92M | 233.06M | 245.84M | 268.08M |
|
|
|||||